Altogether, it is likely that the commonly used AD biomarkers (increased GSK-3β activity, tau protein hyperphosphorylation and Aβ accumulation) are associated with memory impairment in patients with diabetes, suggesting the potential application of these biomarkers in DM patients. Here, MAPT is linked to diabetes mellitus.